Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Intelligent Bio Solutions Inc (INBS)

  • Technical Exchange News
  • Feb. 13, 2024, 18:56 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

NanoString Technologies Inc (NSTG)

  • Technical Exchange News
  • Feb. 13, 2024, 18:53 UTC
  • 35
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Bankrupt. New value: Normal.

Comment Full text

Intelligent Bio Solutions Inc (INBS)

  • Technical Exchange News
  • Feb. 13, 2024, 18:53 UTC
  • 36
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

InVivo Therapeutics Holdings Corp (NVIV)

  • Technical Exchange News
  • Feb. 13, 2024, 00:31 UTC
  • 36
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: InVivo Therapeutics Holdings Corp. - Common Stock.

Comment Full text

InVivo Therapeutics Holdings Corp (NVIV)

  • Technical Exchange News
  • Feb. 13, 2024, 00:31 UTC
  • 38
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: InVivo Therapeutics Holdings Corp. - Common Stock. New value: InVivo Therapeutics Holdings Corp. - Common Stock.

Comment Full text

InVivo Therapeutics Holdings Corp (NVIV)

  • Technical Exchange News
  • Feb. 13, 2024, 00:31 UTC
  • 38
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: InVivo Therapeutics Holdings Corp. - Common Stock.

Comment Full text

InVivo Therapeutics Holdings Corp (NVIV)

  • Technical Exchange News
  • Feb. 12, 2024, 18:51 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Bankrupt. New value: Normal.

Comment Full text

NanoString Technologies Inc (NSTG)

  • Technical Exchange News
  • Feb. 12, 2024, 18:51 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Deficient and Bankrupt.

Comment Full text

FibroGen Inc (FGEN)

  • Technical Exchange News
  • Feb. 12, 2024, 18:51 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Adverum Biotechnologies Inc (ADVM)

  • Technical Exchange News
  • Feb. 12, 2024, 18:51 UTC
  • 36
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 791
  • 792
  • 793
  • 794
  • 795
  • Next

Search

News categories

  • Technical Exchange News(12054)
  • Event(5289)
  • SEC News(250716)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150055)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin